Attached files
| file | filename |
|---|---|
| EX-10.3.1 - EXHIBIT 10.3.1 - ANGIODYNAMICS INC | ex1031stockoptionagreement.htm |
| EX-10.1.7 - EXHIBIT 10.1.7 - ANGIODYNAMICS INC | ex1017totalshareholderretu.htm |
| 10-K - 10-K - ANGIODYNAMICS INC | ango-053118x10k.htm |
| EX-32.2 - EXHIBIT 32.2 - ANGIODYNAMICS INC | ex3225311810-k.htm |
| EX-32.1 - EXHIBIT 32.1 - ANGIODYNAMICS INC | ex3215311810-k.htm |
| EX-31.2 - EXHIBIT 31.2 - ANGIODYNAMICS INC | ex3125311810-k.htm |
| EX-31.1 - EXHIBIT 31.1 - ANGIODYNAMICS INC | ex3115311810-k.htm |
| EX-23.1 - EXHIBIT 23.1 - ANGIODYNAMICS INC | ex231angio2018consentofpri.htm |
| EX-21 - EXHIBIT 21 - ANGIODYNAMICS INC | ex2153118.htm |
| EX-10.4.5 - EXHIBIT 10.4.5 - ANGIODYNAMICS INC | ex1045performanceunitaward.htm |
| EX-10.1.1 - EXHIBIT 10.1.1 - ANGIODYNAMICS INC | ex1011amendmentno1.htm |
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-120057, 333-138456, 333-140627, 333-161355, 333-162844, 333-170619, 333-190640 and 333-203441 on Form S-8 and No. 333-190642 on Form S-3 of our reports dated July 23, 2018 relating to the financial statements and financial statement schedule of AngioDynamics, Inc., and the effectiveness of AngioDynamics Inc.'s internal control over financial reporting, appearing in this Annual Report on Form 10-K of AngioDynamics, Inc. for the year ended May 31, 2018.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
July 23, 2018